Company information:
Ivy Medical Chemicals Development Limited (No: 03426975)
Address: HIGH LEYBOURNE, HASCOMBE ROAD, GODALMING, SURREY, GU8 4AD
Status: Active
Incorporated: 09-Jan-1997
Accounts Next Due: 31-Mar-2025
Next Confirmation Statement Due: 24-Oct-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: ROGER NORMAN ALEXANDER WOOD ( DOB: Sep-1947 From: Aug-2013 )
Current Secretary: ROGER NORMAN ALEXANDER WOOD ( From: Aug-2013 )
Resigned Director: JOHN CARTER ( From: Sep-1997 To: Oct-2007 )
Resigned Director: CLIVE SIDNEY MOSS COHEN ( DOB: Sep-1929 From: Jan-1998 To: May-1998 )
Resigned Director: GEOFFREY ALEXANDER COX ( DOB: Feb-1924 From: May-1999 To: Apr-2001 )
Resigned Director: ANDREW JOHN DUFFIELD ( DOB: Feb-1954 From: May-1999 To: Dec-2010 )
Resigned Director: JOHN MALCOLM HEYWOOD ( DOB: Jan-1936 From: Jan-1999 To: Aug-2013 )
Resigned Director: DAVID JOHN MORRIS ( DOB: Jan-1940 From: May-1999 To: Feb-2009 )
Resigned Director: ROGER ANTHONY OAKES ( DOB: May-1947 From: Nov-2006 To: Mar-2014 )
Resigned Director: ANANT KUMAR PANDYA ( DOB: Oct-1956 From: Nov-2006 To: Dec-2007 )
Resigned Director: DAVID CLIVE SEEL ( DOB: Aug-1947 From: Aug-2013 To: Sep-2016 )
Resigned Secretary: CHETTLEBURGH INTERNATIONAL LIMITED ( From: Sep-1997 To: Sep-1997 )
Resigned Secretary: JOHN MALCOLM HEYWOOD ( DOB: Jan-1936 From: Jan-1999 To: Aug-2013 )
Resigned Secretary: BERNADETTE THERESA QUINN ( From: Sep-1997 To: Jan-1999 )
Persons of Significant Control:
Cv Pharma Limited, High Leybourne Hascombe Road, Godalming, GU8 4AD, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors, Has significant influence or control (Notified: 2016-07-01)
Company Accounts Summary (£)
| Item | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Chart |
|---|---|---|---|---|---|---|---|---|
| Called up share capital not paid, not expressed as current asset | 100 | 100 | 100 | 100.0,100.0,100.0,0.0,0.0,0.0,0.0 | ||||
| Net assets (liabilities) | 100 | 100 | 100 | 100.0,100.0,100.0,0.0,0.0,0.0,0.0 | ||||
| Equity / share capital and reserves | 100 | 100 | 100 | 100.0,100.0,100.0,0.0,0.0,0.0,0.0 |